Differential Response to Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure with Reduced or Preserved Ejection Fraction: Results from the Renal Optimization Strategies Evaluation in Acute Heart Failure (ROSE AHF)

BACKGROUND: The Renal Optimization Strategies Evaluation in Acute Heart Failure (ROSE AHF) trial found that as compared to placebo, neither low-dose dopamine (2 ug/kg/min) nor low-dose nesiritide (0.005 µg/kg/min without bolus) enhanced decongestion or preserved renal function in AHF patients with r...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Circ Heart Fail
Prif Awduron: Wan, Siu-Hin, Stevens, Susanna R., Borlaug, Barry A., Anstrom, Kevin J., Deswal, Anita, Felker, G. Michael, Givertz, Michael M., Bart, Bradley A., Tang, W.H. Wilson, Redfield, Margaret M., Chen, Horng H.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2016
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5034712/
https://ncbi.nlm.nih.gov/pubmed/27512103
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCHEARTFAILURE.115.002593
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg